Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,285
datasets available to search
ShareScore release 0.9.0
Dataset results
2,285 results for “T-cells”
T-Cell Therapy for Advanced Breast Cancer
ClinicalTrials.gov study NCT02792114. IPD Sharing: NO. Countries: 1. Publications: 0.
Recalcitrant Pruritus in Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT00863395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Low-dose IL-2 to the Kinetics of Regulatory T-cell in Healthy Volunteers
ClinicalTrials.gov study NCT03837093. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
ClinicalTrials.gov study NCT03533816. IPD Sharing: NO. Countries: 1. Publications: 0.
IMM 0212: Busulfan With Fludarabine and Antithymocyte Globulin as Preparative Therapy for Hematopoietic Stem Cell Transplant for the Treatment of Severe Congenital T-Cell Immunodeficiency
ClinicalTrials.gov study NCT00228852. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma
ClinicalTrials.gov study NCT03721068. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
ClinicalTrials.gov study NCT05620342. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
ClinicalTrials.gov study NCT05627856. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Alemtuzumab and CHOP Chemotherapy for Aggressive Histological Peripheral T-Cell Lymphomas
ClinicalTrials.gov study NCT00453427. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of WP1220 for the Treatment of Adult Subjects With Cutaneous T-Cell Lymphoma (CTCL)
ClinicalTrials.gov study NCT04702503. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Tria
ClinicalTrials.gov study NCT04539366. IPD Sharing: YES. Countries: 1. Publications: 0.
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
ClinicalTrials.gov study NCT05044039. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma
ClinicalTrials.gov study NCT03235869. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Glofitamab in Relapsed or Refractory Diffuse Large B-cell Lymphoma After CD19 Chimeric Antigen Receptor T-cell Therapy
ClinicalTrials.gov study NCT06552572. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
ClinicalTrials.gov study NCT04803201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Polyspecific Antibodies in Lymphoproliferative T-cell Disorders
ClinicalTrials.gov study NCT06495723. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Evaluating the Effectiveness of Decitabine With Gemcitabine, Oxaliplatin for Relapsed/Refractory Peripheral T-cell Lymphoma
ClinicalTrials.gov study NCT06941688. IPD Sharing: NO. Countries: 1. Publications: 0.
LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma
ClinicalTrials.gov study NCT00412997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia
ClinicalTrials.gov study NCT05281809. IPD Sharing: NO. Countries: 1. Publications: 0.
CD30 CAR T-cells Post AutoHSCT for Poor-risk Hodgkin Lymphoma
ClinicalTrials.gov study NCT06617286. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.